100 related articles for article (PubMed ID: 17975760)
1. [Plasminogen activator inhibitor-1 (PAI-1): pathogenetic role in coronary disease].
Młynarska A; Waszyrowski T; Kasprzak JD
Kardiol Pol; 2007 Sep; 65(9):1109-14. PubMed ID: 17975760
[No Abstract] [Full Text] [Related]
2. [Plasminogen activator inhibitor-1 (PAI-1), ischemic heart disease and diabetes mellitus].
Olexa P; Olexová M
Vnitr Lek; 2003 Mar; 49(3):222-6. PubMed ID: 12728597
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease.
Nordt TK; Peter K; Ruef J; Kübler W; Bode C
Thromb Haemost; 1999 Sep; 82 Suppl 1():14-8. PubMed ID: 10695479
[TBL] [Abstract][Full Text] [Related]
4. [Fibrinolysis in ischemic cardiopathy: the role of plasminogen activator inhibitor 1].
Cesari M; Sartori MT
Cardiologia; 1999 Jan; 44(1):25-32. PubMed ID: 10188326
[No Abstract] [Full Text] [Related]
5. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
[TBL] [Abstract][Full Text] [Related]
6. Looking for the culprit of coronary in-stent restenosis: debatable role for the fibrinolytic system?
Viles-Gonzalez JF; Fuster V
J Thromb Haemost; 2005 Feb; 3(2):230-2. PubMed ID: 15670025
[No Abstract] [Full Text] [Related]
7. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
[TBL] [Abstract][Full Text] [Related]
8. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor 1 and atherothrombosis.
Juhan-Vague I; Alessi MC
Thromb Haemost; 1993 Jul; 70(1):138-43. PubMed ID: 8236090
[No Abstract] [Full Text] [Related]
10. Impaired myocardial t-PA release in patients with coronary artery disease.
Osterlund B; Jern S; Jern C; Seeman-Lodding H; Ostman M; Johansson G; Biber B
Acta Anaesthesiol Scand; 2008 Nov; 52(10):1375-84. PubMed ID: 19025531
[TBL] [Abstract][Full Text] [Related]
11. A slice of PAI.
Loskutoff DJ
J Clin Invest; 1993 Dec; 92(6):2563. PubMed ID: 8254010
[No Abstract] [Full Text] [Related]
12. Telomerase-positive neutrophils: plaque "survivors" and restenosis.
Sane DC
J Am Coll Cardiol; 2008 Jun; 51(25):2443-4; author reply 2444. PubMed ID: 18565405
[No Abstract] [Full Text] [Related]
13. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.
Corsetti JP; Ryan D; Moss AJ; Rainwater DL; Zareba W; Sparks CE
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):548-54. PubMed ID: 18096824
[TBL] [Abstract][Full Text] [Related]
14. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
16. Fracture healing in mice deficient in plasminogen activator inhibitor-1.
Rundle CH; Wang X; Wergedal JE; Mohan S; Lau KH
Calcif Tissue Int; 2008 Oct; 83(4):276-84. PubMed ID: 18820962
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1: a common denominator in cardiovascular disease.
Vaughan DE
J Investig Med; 1998 Oct; 46(8):370-6. PubMed ID: 9805421
[No Abstract] [Full Text] [Related]
18. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
[TBL] [Abstract][Full Text] [Related]
19. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
[TBL] [Abstract][Full Text] [Related]
20. PAI-1 and diabetes: a journey from the bench to the bedside.
Schneider DJ; Sobel BE
Diabetes Care; 2012 Oct; 35(10):1961-7. PubMed ID: 22996180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
